Control of hepatic tumor hemorrhage by transcatheter embolization with Ethibloc.
Two patients with abdominal hemorrhage from a hepatic tumor underwent transcatheter embolization using Ethibloc. The hemorrhage ceased rapidly in both patients. No complications related to the embolization procedure were observed. One patient is doing well after 4 years. The second patient died of extensive metastatic disease eleven weeks after embolization. Control angiography after 14 months and 2 weeks, respectively, demonstrated persistent occlusion of the embolized hepatic arteries. Ethibloc offers the advantage of permanent vascular occlusion and appears to be a safe and effective embolization material for partial occlusion of the hepatic arteries.
Jaschke
W
W
Institut für Klinische Radiologie, Fakultät für Klinische Medizin, Universität Heidelberg, Mannheim, West Germany.
Hoevels
J
J
D000328:Adult; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic; D005227:Fatty Acids; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D006499:Hepatic Artery; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications*; D008875:Middle Aged; D011409:Propylene Glycols; D011506:Proteins; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution